Today, the University of British Columbia (UBC) Board of Governors announced that it has approved the extension of Dr. Michael Coughtrie's appointment as dean of the Faculty of Pharmaceutical Sciences for a second five-year term commencing August 1, 2018.
"Under the leadership of Dr. Coughtrie, the Faculty of Pharmaceutical Sciences has developed a robust strategic plan - Catalyst for Change - for 2017-2022," said Dr. Andrew Szeri, provost and vice-president academic, UBC. "The plan serves to build on the Faculty's many successes and to further its development as one of the leading centres worldwide for research, education and innovation in pharmacy and the pharmaceutical sciences."
Dr. Coughtrie is an accomplished scientist, educator and mentor. Born in Glasgow, Scotland, he received his BSc in biochemistry in 1983 and PhD in 1986 from the University of Dundee where he also began his professional teaching and research career based in the School of Medicine. Dr. Coughtrie's tenure as dean of the Faculty commenced on August 1, 2013. His extensive teaching experience encompasses the development and implementation of a number of course modules in the fields of medicine, dentistry and science. As a researcher focusing on the roles of two major families of drug metabolizing enzymes, he has supervised numerous PhD and postdoctoral students, been invited to speak at over 70 international meetings and conferences, and has received more than 70 competitive research grants and contracts. He is an accomplished and widely cited author and serves on the editorial boards of publications including Pharmacogenetics & Genomics, Xenobiotica, Drug Metabolism Reviews, and Biomarkers. In September 2017, Dr. Coughtrie was elected a Fellow of the Canadian Academy of Health Sciences.
"During his first term, Dr. Coughtrie has also led the Faculty through a period of significant curriculum change and targeted faculty recruitment initiatives," said Dr. Szeri. This included the implementation of the Entry-to-Practice Doctor of Pharmacy (PharmD) program in September 2015, and achieving UBC Senate and Provincial Government approval for the new Flex PharmD program (launching in September 2018)."